Al-Edresi S, Alsalahat I, Freeman S, Aojula H, Penny J (2020) RSV-mediated cleavage of amyloid β1–42 peptide: potential relevance to Alzheimer’s disease. Neurobiol Aging 1(94):24–33

Article  Google Scholar 

Babalola JA, Lang M, George M, Stracke A, Tam-Amersdorfer C, Itxaso I, Lucija D, Tadic J, Schilcher I, Loeffler T, Flunkert S (2023) Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer’s disease-related blood brain barrier dysfunction and inflammation. Brain Res 15(1819):148518

Article  Google Scholar 

Bagno L, Hatzistergos KE, Balkan W, Hare JM (2018) Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther 26(7):1610–1623

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bilal M, Barani M, Sabir F, Rahdar A, Kyzas GZ (2020) Nanomaterials for the treatment and diagnosis of Alzheimer’s disease: an overview. NanoImpact 1(20):100251

Article  Google Scholar 

Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM (2008) Specific Antinociceptive Activity of Cholest-4-en-3-one Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy. J Pharmacol Exp Ther 326(2):623–632

Article  CAS  PubMed  Google Scholar 

Bordet T, Buisson B, Michaud M, Drouot C, Galea P, Delaage P, Akentieva NP, Evers AS, Covey DF, Ostuni MA, Lacapere JJ, Massaad C, Schumacher M, Steidl EM, Maux D, Delaage M, Henderson CE, Pruss RM (2007) Identification and Characterization of Cholest-4-en-3-one Oxime (TRO19622) a Novel Drug Candidate for Amyotrophic Lateral Sclerosis. J Pharmacol Exp Ther 322(2):709–720

Article  CAS  PubMed  Google Scholar 

Chitkara D, Nikalaje SK, Mittal A, Chand M, Kumar N (2012) Development of quercetin nanoformulation and in vivo evaluation using streptozotocin induced diabetic rat model. Drug Deliv Transl Res 2:112–123

Article  CAS  PubMed  Google Scholar 

D’Angelo B, Santucci S, Benedetti E, Di Loreto S, Phani RA, Falone S, Amicarelli F, Ceru MP, Cimini A (2009) Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr Nanosci 5(2):167–176

Article  CAS  Google Scholar 

Deng M, Zhao JY, Tu PF, Jiang Y, Li ZB, Wang YH (2004) Echinacoside rescues the SHSY5Y neuronal cells from TNFα-induced apoptosis. Eur J Pharmacol 505(1–3):11–18

Article  CAS  PubMed  Google Scholar 

Dong L, Kang X, Ma Q, Xu Z, Sun H, Hao D, Chen X (2020) Novel approach for efficient recovery for spinal cord injury repair via biofabricated nano-cerium oxide loaded PCL with resveratrol to improve in vitro biocompatibility and autorecovery abilities. Dose-Response 18(3):1559325820933518

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eckert GP, Eckert SH, Eckmann J, Hagl S, Muller WE, Friedland K (2020) OLX improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer’s disease. Exp Neurol 1(329):113286

Article  Google Scholar 

Elliott RO, He M (2021) Unlocking the power of exosomes for crossing biological barriers in drug delivery. Pharmaceutics 13(1):122

Article  PubMed  PubMed Central  Google Scholar 

Gouarné C, Tracz J, Paoli MG, Deluca V, Seimandi M, Tardif G, Xilouri M, Stefanis L, Bordet T, Pruss RM (2015) Protective role of olesoxime against wild‐type α‐synuclein‐induced toxicity in human neuronally differentiated SHSY‐5Y cells. Br J Pharmacol 172(1):235–245

Article  PubMed  Google Scholar 

Han Q, Cai S, Yang L, Wang X, Qi C, Yang R, Wang C (2017) Molybdenum disulfide nanoparticles as multifunctional inhibitors against Alzheimer’s disease. ACS Appl Mater Interfaces 9(25):21116–21123

Article  CAS  PubMed  Google Scholar 

Hou K, Zhao J, Wang H, Li B, Li K, Shi X, Wan K, Ai J, Lv J, Wang D, Huang Q (2020) Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease. Nat Commun 11(1):4790

Article  CAS  PubMed  PubMed Central  Google Scholar 

Javed I, Peng G, Xing Y, Yu T, Zhao M, Kakinen A, Faridi A, Parish CL, Ding F, Davis TP, Ke PC (2019) Inhibition of amyloid beta toxicity in zebra fish with a chaperone-gold nanoparticle dual strategy. Nat Commun 10(1):3780

Article  PubMed  PubMed Central  Google Scholar 

Kasimov MR, Zakyrjanova GF, Giniatullin AR, Zefirov AL, Petrov AM (2016) Similar oxysterols may lead to opposite effects on synaptic transmission OLX versus 5α-cholestan-3-one at the frog neuromuscular junction. Biochimica Biophysica Acta Mol Cell Bio Lipids. https://doi.org/10.1016/j.bbalip.2016.04.010

Article  Google Scholar 

Kotler SA, Walsh P, Brender JR, Ramamoorthy A (2014) Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer’s disease. Chem Soc Rev 43(19):6692–6700

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee Y, El Andaloussi S, Wood MJ (2012) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21(R1):R125–R134

Article  CAS  PubMed  Google Scholar 

Lee SJC, Nam E, Lee HJ, Savelieff MG, Lim MH (2017) Towards an understanding of amyloid-β oligomers: characterization toxicity mechanisms and inhibitors. Chemi Soc Rev 46(2):310–323

Article  CAS  Google Scholar 

Lenglet T, Lacomblez L, Abitbol JL, Ludolph A, Mora JS, Robberecht W, Shaw PJ, Pruss RM, Cuvier V, Meininger V, Mitotarget Study Group (2014) A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis. Eur J Neurol 21(3):529–536

Article  CAS  PubMed  Google Scholar 

Lu X, Ji C, Xu H, Li X, Ding H, Ye M, Zhu Z, Ding D, Jiang X, Ding X, Guo X (2009) Resveratrol-loaded polymeric micelles protect cells from Aβ-induced oxidative stress. Int J Pharm 375(1–2):89–96

Article  CAS  PubMed  Google Scholar 

Martin LJ (2010) Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis. Drugs Investig J 13(8):568–580

CAS  Google Scholar 

Micci M, Krishnan B, Bishop E, Zhang W, Guptarak J, Grant A, Zolochevska O, Tumurbaatar B, Franklin W, Marino C, Widen SG, Luthra A, Kernie SG, Taglialatela G (2019) Hippocampal stem cells promotes synaptic resistance to the dysfunctional impact of amyloid beta oligomers via secreted exosomes. Mo Neurodegener 14(1):22–25

Google Scholar 

Qi Y, Yi P, He T, Song X, Liu Y, Li Q, Zheng J, Song R, Liu C, Zhang Z, Peng W (2020) Quercetin-loaded selenium nanoparticles inhibit amyloid-β aggregation and exhibit antioxidant activity. Colloids Surf, A 5(602):125058

Article  Google Scholar 

Ren C, Li D, Zhou Q, Hu X (2020) Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model. Biomaterials 232:119752

Article  CAS  PubMed  Google Scholar 

Samai B, Basu A, Mati SS, Bhattacharya SC (2019) Antiamyloid activity of functionalized cerium oxide nanoparticle on lysozyme fibrillation: spectroscopic and microscopic investigation. Materialia 1(6):100285

Article  Google Scholar 

Sharifyrad M, Gohari S, Fathi M, Danafar H, Hosseini MJ, Mostafavi H, Manjili HK (2022) The efficacy and neuroprotective effects of edaravone-loaded mPEG-b-PLGA polymeric nanoparticles on human neuroblastoma SH-SY5Y cell line as in vitro model of ischemia. J Drug Delivery Sci Tech 1(73):103378

Article  Google Scholar 

Shen Y, Cao B, Snyder NR, Woeppel KM, Eles JR, Cui XT (2018) ROS responsive resveratrol delivery from LDLR peptide conjugated PLA-coated mesoporous silica nanoparticles across the blood–brain barrier. J Nanobiotechnol 16(1):13

Article  Google Scholar 

Song N, Sun S, Chen K, Wang Y, Wang H, Meng J, Guo M, Zhang XD, Zhang R (2023) Emerging nanotechnology for Alzheimer’s disease: From detection to treatment. J Control Release 1(360):392–417

Article  Google Scholar 

Sun J, Wei C, Liu Y, Xie W, Xu M, Zhou H, Liu J (2019) Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer’s disease. Biomaterials 1(197):417–431

Article  Google Scholar 

Sunyach C, Michaud M, Arnoux T, Bernard-Marissal N, Aebischer J, Latyszenok V, Gouarné C, Raoul C, Pruss RM, Bordet T, Pettmann B (2012) Olesoxime delays muscle denervation astrogliosis microglial activation and motoneuron death in an ALS mouse model. Neuropharmacol 62(7):2346–2353

Article  CAS  Google Scholar 

Tina CA, Fischer DD, Kostera EM, Heidemarie PB, Carruthers KI (2023) Risdiplam in patients previously treated with other therapies for spinal muscular atrophy: an interim analysis from the JEWELFISH study. Neurol Ther. https://doi.org/10.1007/s40120-023-00444-1

Article  Google Scholar 

Wang Y, An Y, Ma W, Yu H, Lu Y, Zhang X, Wang Y, Liu W, Wang T, Xiao R (2020) 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction. J Neuroinflammation 17(1):1–27

Article  CAS  Google Scholar 

Weber JJ, Clemensson LE, Schiöth HB, Nguyen HP (2019) Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate. Biochem Pharmacol 1(168):305–318

Article  Google Scholar 

Wei R, Zhang L, Hu W, Shang X, He Y, Zhang W (2022) Zeb2/Axin2-Enriched BMSC-derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity. J Mol Neurosci 72:69–81

Article  CAS  PubMed  Google Scholar 

Xu X, Li Z, Zuo H, Chen H, Gui Y (2022) Mesenchymal stem cell-derived exosomes altered neuron cholesterol metabolism via Wnt5a-LRP1 axis and alleviated cognitive impairment in a progressive Parkinson’s disease model. Neurosci Lett 14(787):136810

Article  Google Scholar 

Yu B, Zhang X, Li X (2014) Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15(3):4142–4157

Article  CAS  PubMed  PubMed Central  Google Scholar